Exact Mass: 233.1025

Exact Mass Matches: 233.1025

Found 216 metabolites which its exact mass value is equals to given mass value 233.1025, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

L-Name

N5-[imino(nitroamino)methyl]-L-ornithine, methyl ester

C7H15N5O4 (233.1124)

D004791 - Enzyme Inhibitors

Lomustine

1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea

C9H16ClN3O2 (233.0931)

Lomustine is only found in individuals that have used or taken this drug. It is an alkylating agent of value against both hematologic malignancies and solid tumors. [PubChem]Lomustine is a highly lipophilic nitrosourea compound which undergoes hydrolysis in vivo to form reactive metabolites. These metabolites cause alkylation and cross-linking of DNA (at the O6 position of guanine-containing bases) and RNA, thus inducing cytotoxicity. Other biologic effects include inhibition of DNA synthesis and some cell cycle phase specificity. Nitrosureas generally lack cross-resistance with other alkylating agents. As lomustine is a nitrosurea, it may also inhibit several key processes such as carbamoylation and modification of cellular proteins. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AD - Nitrosoureas C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents

Serylglutamine

(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C8H15N3O5 (233.1012)

Serylglutamine is a dipeptide composed of serine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Asparaginyl-Threonine

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-hydroxybutanoate

C8H15N3O5 (233.1012)

Asparaginyl-Threonine is a dipeptide composed of asparagine and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Threonylasparagine

(2S)-4-Amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-4-oxobutanoic acid

C8H15N3O5 (233.1012)

Threonylasparagine is a dipeptide composed of threonine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Glutaminylserine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-hydroxypropanoate

C8H15N3O5 (233.1012)

Glutaminylserine is a dipeptide composed of glutamine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Serinyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-hydroxypropanoyl)-C-hydroxycarbonimidoyl]butanoate

C8H15N3O5 (233.1012)

Serinyl-Gamma-glutamate is a dipeptide composed of serine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

1-(1,3-Benzodioxol-5-ylcarbonyl)piperidine

1-(2H-1,3-benzodioxole-5-carbonyl)piperidine